Sign in

NCT04340492Completed

Education for Adapted Physical Activity in Parkinson's Disease

Effectiveness of Adapted Physical Activity Education on Physical Activity Daily in Patients With Parkinson's Disease at an Early Stage

Source: ClinicalTrials.gov · Last updated 30 Apr 2026

Brief summary (registry, in English)

Parkinson's disease is a progressive disorders characterized by motor and non-motor symptoms. Actual medical treatments are symptomatic and have little efficacy on late stage axial motor symptoms. Non-pharmacological approaches are therefore essential from the disease onset. Beside physiotherapy, to practice a regular adapted physical activity is crucial. To implement such a practice in everyday life implies to change habits. Patient Education programs are useful tools to help changing behaviors. The study evaluate the effect of a program aiming to promote adapted physical activity in early stage Parkinson's disease by comparing patients receiving the program and patients on a waiting list. The hypothesis that the program will increase the one-week mean daily moderate to intense physical activity as measured with an actimeter.

Status (registry)
Completed
Study type
Interventional
Enrollment
89 (actual)
First submitted
6 Apr 2020
Start date
15 Mar 2021
Primary completion date
28 Oct 2025
Lead sponsor
University Hospital, Lille
NCT number
NCT04340492

What you commit to

  • Study type: Interventional
  • Participants enrolled: 89
  • From 15 Mar 2021 to the primary completion date, 28 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Major depressive disorder according to DSM-V

Other

  • Woman child-bearing or breath-feeding
  • Co-morbidities that influence or contraindicated adapted physical activity (severe respiratory symptoms, cardiopathy…)
  • Significant cognitive trouble (MOCA\<23)
  • Atypical parkinson's

Who the study is looking for

  • suffering from Parkinson's disease according to Movement Disorders Society criteria,
  • with a diagnosis of Parkinson for 3 years or less,
  • with a stable treatment for Parkinson's disease for 3 months or more,
  • having signed the consent form

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hop Salengro - Hopital B Chr Lille
Coordinator of this site? Confirm its status
LilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.